Role of genetic factors and biomarkers in congenital heart defects and neurodevelopmental outcomes

Role of genetic factors and biomarkers in congenital heart defects and neurodevelopmental outcomes

Mark Russell, MD, pediatric cardiologist with U-M C.S. Mott Children’s Hospital’s Congenital Heart Center, discusses the role of biomarkers and influence of genetics on neurodevelopmental outcomes for individuals with CHDs.

Presented at the 6th Annual Cardiac Neurodevelopmental Symposium in June 2017. Learn more about the additional presentations in this series.

C.S. Mott Children’s Hospital is consistently ranked among the nation’s top congenital heart programs in the nation. In 2017, U.S. News & World Report ranked C.S. Mott Children’s Hospital the #3 program in the United States. Learn more at http://www.mottchildren.org/congenital.


Created by

Colleague Connection

Related Presenters

Mark Russell, MD

Mark Russell, MD

Professor

Mark W.Russell, M.D. is a board certified Pediatric Cardiologist with a busy clinical practice and research program. Dr. Russell provides the Pediatric Cardiology services for the Hypertrophic Cardiomypathy Program and the Multidisciplinary ...

View full profile